Industry Growth Insights published a new data on “Typhoid Vaccine Market”. The research report is titled “Typhoid Vaccine Market research by Types (Oral Type Typhoid Vaccine, Injection Type Typhoid Vaccine), By Applications (Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Players/Companies Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical, Merit Pharmaceuticals, Bharat Biotec”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Typhoid Vaccine Market Research Report
By Type
Oral Type Typhoid Vaccine, Injection Type Typhoid Vaccine
By Application
Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others
By Companies
Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical, Merit Pharmaceuticals, Bharat Biotec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Typhoid Vaccine Market Report Segments:
The global Typhoid Vaccine market is segmented on the basis of:
Types
Oral Type Typhoid Vaccine, Injection Type Typhoid Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Merck
- GlaxoSmithKline
- PaxVax
- Actiza Pharmaceutical
- Merit Pharmaceuticals
- Bharat Biotec
Highlights of The Typhoid Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Type Typhoid Vaccine
- Injection Type Typhoid Vaccine
- By Application:
- Hospital
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Typhoid Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Typhoid vaccine is a vaccine that helps protect people from typhoid fever. Typhoid fever is a serious, contagious illness caused by the bacterium Salmonella typhi. Symptoms of typhoid include diarrhea, abdominal pain, and vomiting. Typhoid vaccine can help prevent typhoid infection in people who are at risk for the disease (such as those who are traveling to areas where typhoids are common).
Some of the key players operating in the typhoid vaccine market are Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical, Merit Pharmaceuticals, Bharat Biotec.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Typhoid Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Typhoid Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Typhoid Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Typhoid Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Typhoid Vaccine Market Size & Forecast, 2018-2028
4.5.1 Typhoid Vaccine Market Size and Y-o-Y Growth
4.5.2 Typhoid Vaccine Market Absolute $ Opportunity
Chapter 5 Global Typhoid Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Typhoid Vaccine Market Size Forecast by Type
5.2.1 Oral Type Typhoid Vaccine
5.2.2 Injection Type Typhoid Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Typhoid Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Typhoid Vaccine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Research & Academic Laboratories
6.2.3 Pharmaceutical & Biotechnology Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Typhoid Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Typhoid Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Typhoid Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Typhoid Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Typhoid Vaccine Market Size Forecast by Type
9.6.1 Oral Type Typhoid Vaccine
9.6.2 Injection Type Typhoid Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Typhoid Vaccine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Research & Academic Laboratories
9.10.3 Pharmaceutical & Biotechnology Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Typhoid Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Typhoid Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Typhoid Vaccine Market Size Forecast by Type
10.6.1 Oral Type Typhoid Vaccine
10.6.2 Injection Type Typhoid Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Typhoid Vaccine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Research & Academic Laboratories
10.10.3 Pharmaceutical & Biotechnology Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Typhoid Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Typhoid Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Typhoid Vaccine Market Size Forecast by Type
11.6.1 Oral Type Typhoid Vaccine
11.6.2 Injection Type Typhoid Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Typhoid Vaccine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Research & Academic Laboratories
11.10.3 Pharmaceutical & Biotechnology Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Typhoid Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Typhoid Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Typhoid Vaccine Market Size Forecast by Type
12.6.1 Oral Type Typhoid Vaccine
12.6.2 Injection Type Typhoid Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Typhoid Vaccine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Research & Academic Laboratories
12.10.3 Pharmaceutical & Biotechnology Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Typhoid Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Typhoid Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Typhoid Vaccine Market Size Forecast by Type
13.6.1 Oral Type Typhoid Vaccine
13.6.2 Injection Type Typhoid Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Typhoid Vaccine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Research & Academic Laboratories
13.10.3 Pharmaceutical & Biotechnology Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Typhoid Vaccine Market: Competitive Dashboard
14.2 Global Typhoid Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Merck
14.3.3 GlaxoSmithKline
14.3.4 PaxVax
14.3.5 Actiza Pharmaceutical
14.3.6 Merit Pharmaceuticals
14.3.7 Bharat Biotec
